医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ESC: Providing Asian doctors with the Very Latest in Cardiovascular Science

2019年07月18日 AM09:00
このエントリーをはてなブックマークに追加


 

SINGAPORE

A new congress to improve patient care.

8 to 10 November in Singapore

How can physicians in Asia keep abreast of so many rapidly evolving advances in heart health? A new scientific congress is designed to help.

The European Society of Cardiology (ESC), the world’s largest organisation of healthcare professionals dedicated to fighting heart disease, is joining forces with the Asian Pacific Society of Cardiology (APSC) and the Asean Federation of Cardiology (AFC) to launch ESC ASIA with APSC & ASC in Singapore this November.

“Each year, the ESC alone reviews more than 11,000 abstracts on new cardiovascular science,” said Prof. Michel Komajda, Chair of the Organising Committee. “This new congress will showcase the very latest, most important lessons so that physicians can provide their heart patients with the best possible care.”

This cutting-edge event will help explain the new, all important ESC Clinical Practice Guidelines on Diabetes, Pre-diabetes & Cardiovascular Diseases; Acute Pulmonary Embolism; Chronic Coronary Syndromes; and Dyslipidaemias. In addition, many of the key messages from ESC Congress 2019 in Paris will also be discussed in an Asian Pacific context.

This new congress could not be more timely. According to the World Health Organisation, cardiovascular disease is world’s leading cause of death, killing an estimated 31% of all people. 1 In Singapore alone, it claims 21,000 lives every year. 2

This pioneering event builds on ESC’s reputation in the region as a renowned and trusted learned society. Tens of thousands of healthcare professionals in Asia already turn to the ESC for its prestigious journals, scientific congresses and a variety of unique membership opportunities.

“The ESC is the only global society that covers the full spectrum of cardiology through its many subspecialty communities in Asia,” said Prof. Komajda. “This new event offers physicians of all sorts – from internists and endocrinologists to pulmonologists and cardiologists – the opportunity to exchange ideas with some the most respected cardiovascular researchers from Europe and the Asia Pacific region.”

ENDS

Follow us on Twitter @ESCardioNews

References
1 https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
2 https://www.myheart.org.sg/my-heart/heart-statistics/singapore-statistics/

About the European Society of Cardiology
The European Society of Cardiology brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Register here

View source version on businesswire.com: https://www.businesswire.com/news/home/20190717005652/en/

CONTACT

Authors: ESC Press Office

Justine Pinot

Tel: +33 (0)4 8987 2499

Mobile: +337 (0) 8531 2036

Email: press@escardio.org

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020
  • Exosite授权West Pharmaceutical Services, Inc.使用其物联网技术
  • 武田将呈报ICLUSIG® (ponatinib)临床试验项目数据,这些数据有望改变慢性期CML治疗的实践
  • 武田薬品、高リスクMDS患者でpevonedistatとアザシチジンの併用療法を検討する第2相試験の有力なデータを発表
  • 武田发布Pevonedistat联合阿扎胞苷治疗较高危MDS患者2期试验的有力数据